Editorial Comment: FDG PET/CT Has the Edge Over Whole-Body MRI in the Evaluation of Multiple Myeloma Treatment Response, for Now
AJR Am J Roentgenol
.
2022 Apr;218(4):614.
doi: 10.2214/AJR.21.27066.
Epub 2021 Nov 10.
Author
Fangbai Wu
1
Affiliation
1
Cleveland Clinic, Cleveland, OH wuf@ccf.org.
PMID:
34755527
DOI:
10.2214/AJR.21.27066
No abstract available
Publication types
Editorial
Comment
MeSH terms
Fluorodeoxyglucose F18*
Humans
Magnetic Resonance Imaging
Multiple Myeloma* / diagnostic imaging
Multiple Myeloma* / therapy
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Substances
Fluorodeoxyglucose F18